E-drug: Drug Policy Issues in Developping Countries 2001
-------------------------------------------------------------------------
There has been a delay in sending out the brochures for this course.
Based on the evaluations of past years courses, participants have
found the course very valuable.
While the course is being held in Asia, it is a global course and we
would welcome applicants form Africa, Europe and the Americas.
If you are interested please apply to Sri Suryawati
<suryawati@yogya.wasantara.net.id>
Funding agencies active in the field of pharmaceuticals are also
encouraged to identify possible candidates and nominate them.
With all of the activities occurring related to pharmaceutical policies
this course provides an invaluable opportunity to gain expertise in
this field.
Richard Laing
Associate Professor of International Health
Boston University School of Public Health
715 Albany St, T4W, Boston MA 02118 USA
Tel 617 414-1444 Fax 617 638-4476
E-mail richardl@bu.edu
-----------------
Drug Policy Issues in Developing Countries
-------------------------------------------------------------------------
Boston University School of Public Health, Center for International
Health and Gadjah Mada University, Center for Clinical
Pharmacology and Drug Policy Studies, in collaboration with The
World Health Organization present
DRUG POLICY ISSUES FOR DEVELOPING COUNTRIES
Yogyakarta, October 29 - November 09, 2001
Course Overview
This two-week intensive seminar is intended for policy makers and
senior managers responsible for pharmaceutical systems in
developing countries, and for senior officials of funding agencies.
The faculty is drawn from the World Health Organization, and from
universities in the United States, South Africa, Australia, the
Netherlands, and Indonesia. The seminar's workshop format will
combine lectures, in-depth discussion of case studies, field trips,
and small-group exercises. Enrollment is limited to facilitate
maximum interaction among participants and between participants
and faculty.
The seminar will take place at two venues, one in Yogyakarta and
the other in a nice town near the Borobudur Temple, one of the
Seven Wonders of the World. There will be several field visits to
hospitals and other health facilities and to community pharmacies.
Previous seminars have been held in USA, Africa, India, and
Lebanon.
Over the last 15 years, developing and transitional countries around
the world have adopted essential drug lists, national formularies,
and standard treatment guidelines. But national drug policies require
more than drug lists; hard choices have to be made. In procurement
and production, economies of scale often conflict with support of
domestic industries and protection of national sovereignty. Some
countries are privatizing aspects of their pharmaceutical services.
Controversy over regulation involves fundamental questions about
trade policy and intersectoral collaboration. Once supply
mechanisms function smoothly, rational use demands sustained
attention. How can we ensure that drugs are prescribed and used
appropriately? Is it possible to change ingrained usage patterns?
Finally, what methods most effectively assess how well a country's
drug policy is functioning?
The seminar will address these and other issues intensively. The
highly experienced and knowledgeable faculty will present
up-to-date information and examine the implications of alternative
policy approaches. Participants will also gain valuable insights from
each other's experiences and challenges.
Seminar Topics
Indicators for Monitoring and Evaluating National Drug Policies and
Access to Drugs: Alternative approaches to assessment and
monitoring. Use of different indicators.
Developing and Implementing a National Drug Policy: Alternative
methods of developing and implementing a national drug policy.
Components of drug policy. Case studies.
Selection of drugs in Formularies, and Treatment Guidelines: How
different countries have developed essential drug lists, national
formularies, and treatment guidelines.
Procurement issues and options: Discussion of World Bank papers
on drug procurement. Market intelligence, sources of information.
Quality Assurance: Different approaches to assuring quality in
procurement, production, and use of drugs. Financing and
Pharmaco-economic Issues: Insurance, revolving funds,
fee-for-service, and other financing options. The privatization
option.
Impact of Global trade treaties: Trade and protection issues,
including the TRIPS agreement and WTO.
Human Resource Planning and Development: Assessing the
numbers and training needs of pharmacists and pharmacy
technicians.
Consumer Issues: Involving consumers in improving their access
and use of drugs.
Promoting Rational Use of Drugs: Measuring and changing usage
patterns. Policy implications of recent intervention studies on
methods to improve drug use. Hospital Drug and Therapeutic
Committees.
Drug Policies and Public Health: Effect on drug policies of such
changes in public health as AIDS, TB, Decentralization, Health
Sector Reform.
Faculty
Henk den Besten, the Netherlands.
Edelisa Carandang, Medical Officer, Department of Essential Drugs
and Other Medicines (WHO/EDM).
David Henry, Professor of Clinical Pharmacology, University of
Newcastle, Australia.
Hans Hogerzeil, Coordinator, Policy, Access and Rational Drug Use,
Department of Essential Drugs and Medicines Policy
(WHO/EDM).
Richard Laing, Associate Director, Center for International Health,
Boston University School of Public Health.
Zafar Mirza, Executive Coordinator, Association for Rational Use of
Medication in Pakistan (The Network).
Jonathan Quick, Director, Department of Essential Drugs and Other
Medicines (WHO/EDM).
Budiono Santoso, Regional Adviser Western Pacific Regional Office,
WHO
Rob Summers, Head, School Pharmacy, and Director, Faculty of
Pharmacy, (MEDUNSA), South Africa
Sri Suryawati, Director, Center of Clinical Pharmacology & Drug
Policy Studies, Gadjah Mada University
Kris Weerasuriya, Southeast Asian Regional Office, WHO
Karin Timmermans, WHO-Indonesia
Minor changes may be made in the Faculty.
Course Directors
Richard Laing, Associate Director, Center for International Health
Sri Suryawati, Director, Center for Clinical Pharmacology and Drug
Policy Studies, Gadjah Mada University
Seminar Format
The seminar will meet from 9 a.m. to 4:30 p.m., Monday through
Friday. There will be brief morning and afternoon breaks and a
90-minute lunch break. Dr. Laing and Dr. Suryawati, the course
directors, will attend all sessions to provide continuity. They and
other faculty members will be available to meet with participants
individually and in small groups in the evening. There will be field
visits to hospitals, urban and private health facilities and to
community pharmacies. Participants will be awarded a certificate
upon successful completion of the seminar.
Fees
US$ 3,200 tuition and materials, shared housing from 28 October
to 10 November (13 nights), and meals. Participants requiring an
individual room will be charged an additional $10/night.
Insurance
No medical insurance is included in the seminar fee. Participants are
encouraged to obtain their own medical insurance.
For further information and request for application form:
Sri Suryawati <suryawati@yogya.wasantara.net.id>
Head, Department of Clinical Pharmacology
Faculty of Medicine, Gadjah Mada University
Yogyakarta 55281, Indonesia
Phone: 62 - 274 - 563 596, fax: 62 - 274 - 543711
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://satellife.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.